CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March.
Details for the conferences are as follows:
-
Jefferies Healthcare Services Innovation & Technology Summit
Presentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET
Location: Miami, FL
Presenter: Dr. Daniel Virnich, Chief Executive Officer -
Leerink Global Healthcare Conference
Presentation: Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET
Location: Miami, FL
Presenter: Rob Carter, Chief Financial Officer -
Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Presentation: Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET
Location: Virtual
Presenters: Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer
Where available, live webcasts and replays of the presentations will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (
www.theoncologyinstitute.com
):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
[email protected]
Investors
ICR Healthcare
[email protected]
